Scarica l'app Stockscreener
26.48
7.61%
-2.18
Dopo l'orario di chiusura:
26.29
-0.19
-0.72%
Precedente Chiudi:
$28.66
Aprire:
$29.14
Volume 24 ore:
1.75M
Relative Volume:
1.90
Capitalizzazione di mercato:
$1.59B
Reddito:
$439.00K
Utile/perdita netta:
$-105.64M
Rapporto P/E:
-14.71
EPS:
-1.8
Flusso di cassa netto:
$-60.70M
1 W Prestazione:
-7.77%
1M Prestazione:
+16.70%
6M Prestazione:
+3.04%
1 anno Prestazione:
-51.15%
Intervallo 1D:
$24.91
$29.14
Intervallo di 1 settimana:
$24.91
$29.21
Portata 52W:
$21.73
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
Nome
Janux Therapeutics Inc
Settore
Industria
Telefono
(858) 751-4493
Indirizzo
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Confronta JANX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
26.48 | 1.72B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Barclays | Overweight |
| 2025-09-10 | Iniziato | Stifel | Buy |
| 2025-09-10 | Iniziato | Truist | Buy |
| 2025-09-04 | Iniziato | Guggenheim | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-11 | Iniziato | Raymond James | Outperform |
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-12-03 | Reiterato | H.C. Wainwright | Buy |
| 2024-11-22 | Iniziato | Leerink Partners | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Scotiabank | Sector Perform |
| 2024-03-21 | Iniziato | BTIG Research | Buy |
| 2024-03-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-06 | Iniziato | Wedbush | Outperform |
| 2022-11-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Janux Therapeutics Inc Borsa (JANX) Ultime notizie
Janux Therapeutics price target raised to $46 from $45 at Stifel - TipRanks
JANX December 2026 Options Begin Trading - Nasdaq
Why Janux Therapeutics Inc. stock remains undervaluedJuly 2025 Breakouts & Expert-Curated Trade Recommendations - newser.com
Janux Therapeutics price target raised to $48 from $47 at Barclays - TipRanks
Buy Rating for Janux Therapeutics: Promising Data and Strong Financial Position Highlight Growth Potential - TipRanks
Janux Therapeutics Reports Strong Financial Position Amid Clinical Advancements - TipRanks
Janux Therapeutics Keeps Spending Up As Losses Narrow - Finimize
The Technical Signals Behind (JANX) That Institutions Follow - news.stocktradersdaily.com
Buy Rating on Janux Therapeutics Inc: Strong Financials and Promising Clinical Developments - TipRanks
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights - BioSpace
Janux Therapeutics earnings beat by $0.23, revenue topped estimates - Investing.com Canada
Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Promising Pipeline and Strategic Developments Justify Buy Rating for Janux Therapeutics Inc. - TipRanks
Earnings Flash (JANX) Janux Therapeutics, Inc. Reports Q3 Revenue $10.0M, vs. FactSet Est of $2.9M - MarketScreener
Janux Therapeutics Q3 net loss narrows, R&D expenses rise - TradingView
Relative strength of Janux Therapeutics Inc. in sector analysisJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Will Janux Therapeutics Inc. price bounce be sustainableRisk Management & Expert Approved Momentum Trade Ideas - newser.com
Is Janux Therapeutics Inc. stock a safe buy before earningsWeekly Investment Report & Technical Confirmation Alerts - newser.com
Can Janux Therapeutics Inc. stock surprise with earnings upsideWeekly Market Outlook & Daily Price Action Insights - newser.com
How Janux Therapeutics Inc. stock benefits from strong dollar2025 Performance Recap & Fast Moving Stock Trade Plans - fcp.pa.gov.br
Using fundamentals and technicals on Janux Therapeutics Inc.Quarterly Earnings Summary & Weekly Momentum Stock Picks - newser.com
Is Janux Therapeutics Inc. stock attractive for income investorsJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Volume spikes in Janux Therapeutics Inc. stock – what they meanJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
Janux Therapeutics, Inc. (JANX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Restile Ceramics Limited Stock Discounted Enough After Recent DeclinesRSI Overbought/Oversold & Fast Profit Stock Ideas - earlytimes.in
Janux Therapeutics, Inc. (JANX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What analysts say about Janux Therapeutics Inc stockTechnology Stock Trends & Turn Data into Profits With Our Strategies - earlytimes.in
AlphaQuest LLC Has $224,000 Stock Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat
Insider Selling: Janux Therapeutics (NASDAQ:JANX) Insider Sells 16,665 Shares of Stock - MarketBeat
Janux Therapeutics Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Janux Therapeutics Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com
Insider Sell: Andrew Meyer Sells Shares of Janux Therapeutics In - GuruFocus
Janux therapeutics CBO Meyer sells $500k in shares By Investing.com - Investing.com Canada
Janux Therapeutics Inc Azioni (JANX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):